Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Richman

Showing results (191-200 of 210) with videos related to

Pageof 21
Sort By:
Cancer|October 15, 1982
The natural history of resectable metastatic melanoma (Stage IVA melanoma)L G Feun, J Gutterman, M A Burgess, et al.
The Journal of Clinical Investigation|June 5, 2019
Tumor cell-intrinsic EPHA2 suppresses anti-tumor immunity by regulating PTGS2 (COX-2)Nune Markosyan, Jinyang Li, Yu H Sun, et al.
International Journal of Colorectal Disease|May 3, 2005
Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?R Hughes, R Glynne-Jones, J Grainger, et al.
Nature Biotechnology|January 19, 2023
Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cellsSangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, et al.
Nature Communications|July 17, 2021
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targetingAdham S Bear, Tatiana Blanchard, Joseph Cesare, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity ConditioningRan Reshef, Austin P Huffman, Amy Gao, et al.
Oncoimmunology|October 6, 2018
Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanomaDavid L Bajor, Rosemarie Mick, Matthew J Riese, et al.
Nature Biotechnology|November 14, 2024
Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cellsSangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 10, 2005
The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapyM Beresford, R Glynne-Jones, P Richman, et al.
American Journal of Hematology|February 10, 2016
Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftmentElizabeth O Hexner, Selina M Luger, Ran Reshef, et al.
Pageof 21

Showing results (191-200 of 210) with videos related to

Sort By:
Pageof 21
Cancer|October 15, 1982
The natural history of resectable metastatic melanoma (Stage IVA melanoma)L G Feun, J Gutterman, M A Burgess, et al.
The Journal of Clinical Investigation|June 5, 2019
Tumor cell-intrinsic EPHA2 suppresses anti-tumor immunity by regulating PTGS2 (COX-2)Nune Markosyan, Jinyang Li, Yu H Sun, et al.
International Journal of Colorectal Disease|May 3, 2005
Can pathological complete response in the primary tumour following pre-operative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for sterilisation of pelvic lymph nodes, a low risk of local recurrence and the appropriateness of local excision?R Hughes, R Glynne-Jones, J Grainger, et al.
Nature Biotechnology|January 19, 2023
Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cellsSangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, et al.
Nature Communications|July 17, 2021
Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targetingAdham S Bear, Tatiana Blanchard, Joseph Cesare, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2015
High Graft CD8 Cell Dose Predicts Improved Survival and Enables Better Donor Selection in Allogeneic Stem-Cell Transplantation With Reduced-Intensity ConditioningRan Reshef, Austin P Huffman, Amy Gao, et al.
Oncoimmunology|October 6, 2018
Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanomaDavid L Bajor, Rosemarie Mick, Matthew J Riese, et al.
Nature Biotechnology|November 14, 2024
Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cellsSangwook Oh, Xuming Mao, Silvio Manfredo-Vieira, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 10, 2005
The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapyM Beresford, R Glynne-Jones, P Richman, et al.
American Journal of Hematology|February 10, 2016
Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftmentElizabeth O Hexner, Selina M Luger, Ran Reshef, et al.
Pageof 21